Delivery Order SPE2DB20D3303-SPE2DB24FY3S9

Award Date 11/22/23
Potential Completion Date 11/24/23
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,816.84 Firm Fixed Price Delivery Order is for the supply of 4,560,394,455 phytonadione 5 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.66 firm fixed price delivery order is for the supply of 4566577227 - Phytonadione 5 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.17 firm-fixed-price delivery order contract is for the supply of 4561452281 Phytonadione 5 mg Tablets in 30s. The contract has a performance period through July 11, 2023 and was not set aside for any specific business category. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs)...
This contract award, valued at $8,140.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Phytonadione 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,603.78 firm fixed-price delivery order is for the supply of 4566164740 PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $4,449.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4564618186 - PHYTONADIONE 5 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWLED, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,532.73 firm-fixed-price delivery order is for the supply of 4568031837 - Phytonadione .5ML 10S, a medical product. This award is not set-aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,289.64, is for the delivery of 4,567,442,998 units of the medication phytonadione 1 mg/0.5 ml syringe. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,843.36, is for the delivery of phytonadione 1 mg/0.5 ml syrup (0.5 ml). This is a firm fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $1,295.66 firm fixed-price delivery order contract for the supply of 4565164777 - Phytonadione 1 mg/0.5 ml syringes. This contract is a child order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FY3S9
    Delivery Order

The federal contract award SPE2DB20D3303|SPE2DB24FY3S9 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,349.32 firm-fixed-price delivery order is for the supply of Phytonadione 5 mg tablets. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:11 AM